Sildenafil, Nitric Oxide, and Acute Lung Injury: Pathophysiology Beats Pharmacotherapy?

Pediatric Research

Volumn 55, Issue 3, 2004, Pages 370-371

  Schulze Neick, Ingram ^a   Redington, Andrew N ^b  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PROSTANOID; SILDENAFIL; ZAPRINAST;

ADVERSE DRUG REACTION; BLOOD CLOTTING DISORDER; DRUG BLOOD LEVEL; HUMAN; LUNG CIRCULATION; LUNG INJURY; LUNG VASCULAR RESISTANCE; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; VASODILATATION;

ADMINISTRATION, INHALATION; ANIMALS; HUMANS; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES;

EID: 1242342200     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000112096.46811.BE     Document Type: Note

References (19)

1. Moncada S, Higgs A 1993 The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012
2. Gibson A 2001 Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil. Eur J Pharmacol 411:1-10
3. Kaisers U, Busch T, Deja M, Donaubauer B, Falke KJ 2003 Selective pulmonary vasodilation in acute respiratory distress syndrome. Crit Care Med 31:S337-S342
4. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP 2000 Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 342:469-474
5. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ 1993 Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 88:2128-2138
6. Truog WE, Castor CA, Sheffield MJ 2003 Neonatal nitric oxide use: predictors of response and financial implications. J Perinatol 23:128-132
7. Rabe KF, Tenor H, Dent G, Schudt C, Nakashima M, Magnussen H 1994 Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am J Physiol 266:L536-L543
8. Wilkens H, Guth A, Konig J, Forestier N, Cremers B, Hennen B, Bohm M, Sybrecht GW 2001 Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 104:1218-1222
9. Molina J, Lucero E, Luluaga S, Bellomio V, Spindler A, Berman A 2003 Systemic lupus erythematosus-associated pulmonary hypertension: good outcome following sildenafil therapy. Lupus 12:321-323
10. Ghofrani HA, Schermuly RT, Rose F, Wiedemann R, Kohstall MG, Kreckel A, Olschewski H, Weissmann N, Enke B, Ghofrani S, Seeger W, Grimminger F 2003 Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 167:1139-1141
11. Littera R, La Nasa G, Derchi G, Cappellini MD, Chang CY, Contu L 2002 Long-term treatment with sildenafil in a thalassemic patient with pulmonary hypertension. Blood 100:1516-1517
12. Carlsen J, Kjeldsen K, Gerstoft J 2002 Sildenafil as a successful treatment of otherwise fatal HIV-related pulmonary hypertension. Aids 16:1568-1569
13. Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, Gunther A, Walmrath D, Seeger W, Grimminger F 2002 Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 360:895-900
14. Abrams D, Schulze-Neick I, Magee AG 2000 Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 84:E4
15. Michelakis ED 2003 The role of the NO axis and its therapeutic implications in pulmonary arterial hypertension. Heart Fail Rev 8:5-21
16. Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, Hubler M, Butrous G, Petros A, Lange P, Redington AN 2003 Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 108:11167-11173
17. Shekerdemian LS, Ravn HB, Penny DJ 2002 Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 165:1098-1102
18. Turko IV, Ballard SA, Francis SH, Corbin JD 1999 Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (type 5) by sildenafil and related compounds. Mol Pharmacol 56:124-130
19. Radermacher P, Santak B, Becker H, Falke KJ 1989 Prostaglandin El and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology 70:601-606